MENU
INNPD
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Innocan Pharma (INNPD) Ownership - Who owns Innocan Pharma?
InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals... Show more
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
33.6M
P/E Ratio
N/A
Total Cash
7.26M
Projected Growth
N/A
Total Debt
1.4M
Revenue
28.83M
Risk (Beta)
0.80
Dividend Yield
N/A
Total Cash/Share
1.61
Total Debt/Equity
N/A
Revenue/Share
6.51 USD as % of share price
Fundamentals
INNPD
Capitalization
33.6M
P/E Ratio
N/A
Risk (Beta)
0.80
Dividend Yield
N/A
Total Cash
7.26M
Total Cash/Share
1.61
Total Debt
1.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.51%
Revenue
28.8M
ROE
N/A
Book Value
4.21M
P/B Ratio
8.58
Cash Flow
N/A
Earnings
-0.58
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
3.70
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
675K
Float
N/A
Float - Current
N/A
Gross Income Margin
88.42
Revenue To Assets
-15.96
Shares Held By Institutions
0
Shares Outstanding - Current
4.5M
Total Liabilities
4.35M
Total Volume MTD
N/A
Value
N/A
Gain YTD
5014.796
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information